BackEditas Medicine Overview

Editas Medicine Long Term Debt

Track Editas Medicine's long-term debt ($9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$9.00M
86.50% YoYΔ $-57.66M vs prior year quarter

Peer trimmed avg / median

Loading

Editas Medicine Long Term Debt History

Loading

Editas Medicine vs. peers: Long Term Debt Comparison

Loading

Editas Medicine Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Editas Medicine (EDIT) FAQ

As of the most recent data (June 2026), EDIT shows a long-term debt of $9M. That compares with $67M in the prior-year period — down 86.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EDIT's long-term debt is now $9M (was $67M) — a 86.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Editas Medicine is outperforming or lagging.

Tracking EDIT's long-term debt over time shows whether Editas Medicine is scaling, shrinking, or reshaping that part of the business. The current reading is $9M That compares with $67M in the prior-year period — down 86.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Editas Medicine's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $9M) with ownership activity and broader fundamentals.

Editas Medicine's long-term debt is $9M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.